Please assess the completion status of the following clinical trial:

Trial Title: HAART Annuloplasty Device Valve Repair Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* The patient underwent or is undergoing aortic valve repair using either the HAART 300 or HAART 200 Aortic Annuloplasty Device in accordance with the Instructions for Use.~* The patient has reviewed and signed the written informed consent form.~* The patient agrees to return for all follow-up evaluations for the duration of the study.~Exclusion Criteria:~* Retrospective patient that has undergone a subsequent aortic valve replacement procedure.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HAART 300 (Type: None): HAART 300 Aortic Annuloplasty Device
- HAART 200 (Type: None): HAART 200 Aortic Annuloplasty Device

Based on this trial design, predict the completion outcome and termination type (if applicable).